-
Nov 30, 2015, 15:45 PM
by
Michael Croft
Bio-IT World | Human Longevity this morning announced that it has acquired Cypher Genomics for an undisclosed amount. Cypher has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI's Pediatric Business.
Full story
-
Nov 30, 2015, 15:34 PM
by
Michael Croft
Wired | uBiome has announced a partnership with the Centers for Disease Control and Prevention to develop a standardized way of measuring disruptions and changes to the human microbiome.
Full story
-
Nov 30, 2015, 10:58 AM
by
Michael Croft
The Atlantic | CRISPR-Cas9 experiments are revealing which human genes are essential, and which matter specifically to cancer cells.
Full story
-
Nov 30, 2015, 03:31 AM
by
Michael Croft
ULSAN, SOUTH KOREA - Nov 24, 2015 - Alzheimer's disease (AD) is one of the most well-known and common form of dementia. It is also a progressive, degenerative brain disease whose cause is not fully understood, however, amyloid-β (Aβ) peptides, metal ions and reactive oxygen species (ROS) have been suggested to be involved in AD pathogenesis
Full story
-
Nov 26, 2015, 09:30 AM
by
Michael Croft
BOSTON, MA - Nov 26, 2015 - The creators behind sciNote - an open source electronic laboratory notebook (ELN) - believe that laboratories deserve reliable and easy-to-use software at affordable prices
Full story
-
Nov 25, 2015, 11:40 AM
by
Michael Croft
Diagnostics World | Quanterix, the Lexington, Mass.-based creator of a high-throughput protein analysis instrument, is overhauling its hardware and software as it prepares for a more commercial stage in its development.
Full story
-
Nov 24, 2015, 10:40 AM
by
Michael Croft
Bio-IT World News Brief | Complete Genomics of Mountain View, Calif., is undergoing a big shakeup under the direction of its Shenzhen-based owner BGI, reorganizing as a research site developing assays for the BGISEQ-500 and cutting short the launch of its Revolocity clinical sequencing system.
Full story
-
Nov 24, 2015, 08:21 AM
by
Michael Croft
ULSAN, KOREA - Nov 25, 2015 - The Ulsan 10,000 Genome Project, entitled the "Genome Korea in Ulsan" has been launched in Ulsan Metropolitan City on the 25th of Nov
Full story
-
Nov 23, 2015, 15:53 PM
by
Michael Croft
STAT | Scientists have used the CRISPR-Cas9 genome-editing tool to create mosquitoes that block the malaria parasite instead of transmitting it - and rapidly spread their modified DNA to nearly all their descendants.
Full story
-
Nov 20, 2015, 13:15 PM
by
Michael Croft
Bio-IT World | Thermo Fisher Scientific announced this week that it will be creating a next-generation sequencing test as a companion diagnostic in cases of non-small cell lung cancer, partnering with Novartis and Pfizer.
Full story
-
Nov 20, 2015, 09:24 AM
by
Michael Croft
BASEL, N/A, SWITZERLAND - Nov 20, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it has signed a five-year license agreement with AstraZeneca
Full story
-
Nov 19, 2015, 10:55 AM
by
Michael Croft
Bio-IT World | Oxford Nanopore, creator of the handheld MinION DNA sequencer, recently revealed its first user-facing tool for genetic interpretation, a species identification workflow called What's in my Pot? The tool, designed by Oxford's software spinout Metrichor, hints at the company's ambitions to bring DNA analysis to a much wider audience, as the MinION broadens notions of who can perform sequencing and where.
Full story
-
Nov 19, 2015, 09:17 AM
by
Michael Croft
Nature News | The idea of two sexes, divided neatly by X and Y chromosomes, is simplistic. Biologists are now finding a fascinating number and variety of ways genetics can defy the binary.
Full story
-
Nov 19, 2015, 05:39 AM
by
Michael Croft
NOTTINGHAM, UNITED KINGDOM - Nov 19, 2015 - Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabiliThe move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to develop the technique to complement its development services and help get new molecules to Phase I clinical trials quicker
Full story
-
Nov 18, 2015, 11:39 AM
by
Michael Croft
- Nov 18, 2015 - Cogstate Ltd (ASX: CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Full story
-
Nov 18, 2015, 10:05 AM
by
Michael Croft
Bio-IT World | Deep Genomics this morning announced the closing of $3.7 million in seed financing. Funding was led by True Ventures of the Bay Area with participation from Bloomberg Beta and other global angel investors.
Full story
-
Nov 17, 2015, 09:50 AM
by
Michael Croft
Forbes | Doug Williams left one of biotechnology's biggest jobs, at Biogen, in July. Now we know why. Williams is now the founding CEO of Codiak Biosciences, a Cambridge, Mass.-based startup. The little company is announcing today it has raised $80 million in committed venture capital spread over two installments.
Full story
-
Nov 16, 2015, 15:16 PM
by
Michael Croft
HELSINKI, FINLAND - Nov 16, 2015 - BC Platforms today announced that it has appointed Mark Daly as the Chairman of its Scientific Advisory Board (SAB) and expanded its senior management team who will be located at its new US headquarters in Cambridge, Massachusetts, USA
Full story
-
Nov 16, 2015, 15:00 PM
by
Michael Croft
NCBI News | In early January, NCBI will host a genomics hackathon with teams taking on network analysis of variants, structural variation, RNA-seq, streaming data and metadata, and more.
Full story
-
Nov 16, 2015, 14:49 PM
by
Michael Croft
MIT Technology Review | A survey finds that consumers are wary of giving their personal health information to insurers, pharma companies, government, and especially tech companies like Google, Apple and Facebook.
Full story